key: cord-0847476-m6g746nz
authors: Chen, Yung-Che; Hsu, Po-Yuan; Chin, Chien-Hung; Hsiao, Chang-Chun; Liou, Chia-Wei; Wang, Ting-Ya; Lin, Yong-Yong; Lee, Chiu-Ping; Lin, Hsin-Ching; Lin, Meng-Chih; Su, Mao-Chang
title: H3K23/H3K36 hypoacetylation and HDAC1 up-regulation are associated with adverse consequences in obstructive sleep apnea patients
date: 2021-10-19
journal: Sci Rep
DOI: 10.1038/s41598-021-00052-9
sha: 0a1bc9daf222760eb6789fbedaa6900edbc05f91
doc_id: 847476
cord_uid: m6g746nz

The aim of this study is to determine the roles of global histone acetylation (Ac)/methylation (me), their modifying enzymes, and gene-specific histone enrichment in obstructive sleep apnea (OSA). Global histone modifications, and their modifying enzyme expressions were assessed in peripheral blood mononuclear cells from 56 patients with OSA and 16 matched subjects with primary snoring (PS). HIF-1α gene promoter-specific H3K36Ac enrichment was assessed in another cohort (28 OSA, 8 PS). Both global histone H3K23Ac and H3K36Ac expressions were decreased in OSA patients versus PS subjects. H3K23Ac expressions were further decreased in OSA patients with prevalent hypertension. HDAC1 expressions were higher in OSA patients, especially in those with excessive daytime sleepiness, and reduced after more than 6 months of continuous positive airway pressure treatment. H3K79me3 expression was increased in those with high C-reactive protein levels. Decreased KDM6B protein expressions were noted in those with a high hypoxic load, and associated with a higher risk for incident cardiovascular events or hypertension. HIF-1α gene promoter-specific H3K36Ac enrichment was decreased in OSA patients versus PS subjects. In vitro intermittent hypoxia with re-oxygenation stimuli resulted in HDAC1 over-expression and HIF-1α gene promoter-specific H3K36Ac under-expression, while HDAC1 inhibitor, SAHA, reversed oxidative stress through inhibiting NOX1. In conclusions, H3K23/H3K36 hypoacetylation is associated with the development of hypertension and disease severity in sleep-disordered breathing patients, probably through up-regulation of HDAC1, while H3K79 hypermethylation is associated with higher risk of cardiovascular diseases, probably through down-regulation of KDM6B.

To determine the role of global histone acetylation/methylation in the development of OSA and comorbidities, protein levels of H3K9Ac, H3K14Ac, H3K23Ac, H3K36Ac, H3K56Ac, H4K16Ac, H3K4me3, H3K9me3, H3K27me3, H3K36me3, and H3K79me3 were measured in the PBMC samples from cohort 1. These modification sites were chosen based on their known biological effects on gene expressions and the accessibility of the ELISA kits [8] [9] [10] . Both global histone H3K23Ac (2.5 ± 0.51 versus 2.83 ± 0.53 ng/μl, adjusted p = 0.03, Fig. 1A ) and H3K36Ac (1.34 ± 0.39 versus 1.88 ± 0.94 ng/μl, adjusted p = 0.039, Fig. 1B ) expressions were significantly decreased in OSA patients as compared with that in PS subjects, while the other global histone modification expressions were not different between OSA and PS groups ( Supplementary Fig. S1 ). H3K23Ac expression was negatively correlated with both AHI (r = − 0.26, p = 0.028, Fig. 1C ).The correlation remained statistically significant in multivariate linear regression analysis model 2 (Supplementary Table S1 ), but did not reach statistical significance in the analysis of separate PS and OSA groups. H3K36Ac expression was negatively correlated with both AHI (r = − 0.341, p = 0.003, Fig. 1D ) and ODI (r = − 0.242, p = 0.041, Fig. 1E ), and positively correlated with minimum SaO2 (r = 0.292, p = 0.013, Fig. 1F ). The three correlations remained statistically significant in multivariate linear regression analyses model 1 or 2 (Supplementary Tables S2, S3 , S4), but were reduced in separate PS and OSA groups. Subgroup analysis revealed that global histone H3K23Ac expression was further decreased in OSA patients with prevalent hypertension (n = 20, 2.32 ± 0.32 ng/μl, Fig. 1G www.nature.com/scientificreports/ hypertension (n = 36, 2.61 ± 0.56 ng/μl, p = 0.042/adjusted p = 0.037) or PS subjects (p = 0.004/adjusted p = 0.006). Furthermore, global histone H3K79me3 expression was increased in OSA patients with high serum hsCRP levels (n = 21, hsCRP > 3; 1.56 ± 0.71 ng/μl; Fig. 1H ) versus those with low serum hsCRP levels (n = 35, hsCRP≦3; 1.17 ± 0.4 ng/μl, p = 0.005/adjusted p = 0.008) or PS subjects (1.11 ± 0.51 ng/μl, p = 0.048/adjusted p = 0.023) 15 .

Gene and protein expression changes of specific histone modifying enzymes responsible for the global histone methylation/acetylation patterns. To www.nature.com/scientificreports/ www.nature.com/scientificreports/ in patients with OSA, we next investigated whether such hypoacetylation occurred specifically at the promoter regions of the HIF-1α and HIF-2α genes. We examined this possibility by ChIP method in PBMC lysates from another cohort (cohort 2) of 28 treatment-naïve OSA patients, and 8 matched PS subjects (Table 1) . H3K36Ac enrichment over the HIF-1α (0.52 ± 0.92 versus 1.23 ± 1.25 fold change, adjusted p = 0.006; Fig. 2H ) gene promoter region was decreased in the treatment-naïve OSA patients as compared with that in the PS subjects. This specific histone modification was negatively correlated with both AHI (r = − 0.548, p = 0.001, Fig. 2I ) and ODI (r = − 0.449, p = 0.006, Fig. 2J ), and positively with minimum SaO2 (r = 0.434, p = 0.008, Fig. 2K ). These correlations remained statistically significant in multivariate linear regression model 1 or model 2 (Supplementary  Tables S5, S6 , S7), but did not reach statistical significance in the analysis of separate PS and OSA groups. Additionally, H3K36 Ac enrichment over the HIF-2α gene promoter region (0.49 ± 0.3 versus 1.03 ± 1.06 fold change, adjusted p = 0.024, Supplementary Fig. S4 ) was decreased in the treatment-naïve OSA patients versus the PS subjects. However, this difference was not normally distributed and did not reach statistical significance in the non-parametric analysis. Moreover, no significant difference in either HIF-1α or HIF-2α gene expression level was noted between case and control groups ( Supplementary Fig. S4 ). 

Epigenetic changes are involved in the switching ' on' and ' off ' of many genes, and histone modifications has been regarded as epigenetic gene targets for the regulation of disease-associated cellular changes in hypoxic microenvironment. Little is known about the role of histone modifications in OSA, which is characterized by chronic IHR rather than persistent hypoxia. Therefore, in this study, we sought to identify specific histone modification patterns associated with OSA and its clinical phenotypes. We have proved, for the first time, the relationship between global H3K23/H3K36 hypoacetylation in association with HDAC1 up-regulation and the development of EDS/hypertension phenotype in OSA patients. Specifically, HIF-1α gene promoter-specific H3K36 enrichment was decreased in OSA patients and in response to in vitro IHR stimuli. In contrast, global H3K79 hypermethylation along with KDM6B down-regulation was found to be related to higher incident cardiovascular risk. Additionally, we found that SAHA, a HDAC inhibitor, could reverse IHR-induced ROS over-production through NOX1 in vitro. H3K36Ac is localized predominantly to the promoters of RNA polymerase II-transcribed genes, a pattern inversely related to that of H3K36 me 16 . H3K36 acetylation has been shown to increase chromatin accessibility, and promotes DNA double-strand break repair. Furthermore, H3K36 modification is cell cycle regulated with chromatin-bound H3K36me3 peaking in G1 where non-homologous end joining occurs, while H3K36Ac peaking in S/G2 phase when homologous recombination predominates 17 . The H3K36 hypoacetylation in OSA patients and in response to in vitro short-term IHR stimuli suggest that DNA double-strand break repair may be dampened by chronic IHR in OSA through H3K36 hypoacetylation. The decreased enrichment of H3K36 acetylation over the HIF-1α gene promoter region in OSA patients and in response to IHR stimuli suggest that H3K36Ac may play a specific role in regulating HIF-1α-mediated adaptive responses to hypoxia. However, separate cohorts were used for the global histone and HIF-1α promoter-specific histone enrichment analyses, and this may limit the cause-effect interpretation of the experiments. Moreover, correlations between global H3K23Ac/H3K36Ac expression and metrics such as AHI, arousal index, mean SaO2 were quite weak, so further studies are needed. Finally, many environmental exposures, such as cigarette smoking, may cause specific histone modification change. In the lung tissues of smokers with COPD, the expressions of HDAC2, HDAC5, HDAC8, HDAC7, and HDAC10 were decreased significantly, while H3K23Ac or H3K36Ac has not yet been linked to smoking exposure 18 . However, we applied multivariate linear regression models to adjust for all possible confounding factors.

In line with our findings that global H3K23 was hypoacetylated in OSA patients, H3K23 acetylation has been reported to be reduced in diabetic mice, and its hypo-acetylation contributed to Drosophila learning defect and depression-like behaviors in rats [19] [20] [21] . Since the co-existence of both H4K16ac and H3K23ac was correlated with higher gene expression levels in a plant study, and lipopolysaccharide can trigger IL-6 production via enhancing recruitment of H3K23 acetylation to IL-6 promoter region, we speculated that the simultaneous hypoacetylation of H3K36 and H3K23 in OSA patients may lead to impaired DNA repair ability under chronic IHR circumstances, and affect specific adaptive gene responses through regulating HIF-1α 22, 23 .

Up-regulation of HDAC1 has been shown to be associated with adverse prognosis of various cancers, and plays critical roles in cellular senescence, aging, myelination, and adult neurogenesis 24 . In line with our findings that HDAC1 was up-regulated in OSA patients and in response to IHR stimuli, HDAC1 inhibition was reported to protect against hypoxia-induced swelling in cardiomyocytes through enhancing cell stiffness 25 www.nature.com/scientificreports/ conditions through binding to the oxygen-dependent degradation domain of HIF-1α 26 . Although HDAC1 expressions were reduced after CPAP treatment in a small group of OSA patients, the lack of a time control group or sham CPAP device and the lack of CPAP adherence data limit the interpretation of these data. In line with our findings that HDAC3 was down-regulated in OSA patients with high hypoxic load, HDAC3 has been reported to mediate cardioprotection of remifentanil post-conditioning by targeting GSK-3beta in cardiomyocytes in IHR injury 27, 28 . In contrast, HDAC3 could contribute to IHR-induced cell apoptosis of myocardioblasts 28 . However, the reversion of IHR-induced ROS over-production with SAHA through inhibition of the NOX1 gene indicates that HDAC1/3 inhibition may be a new therapy to reduce oxidative stress in OSA. Several recent studies have shown that HDAC inhibition with SAHA, trichostatin A, or valproic acid, reduced ROS production in experimental diabetes, pulmonary hypertension, and atherosclerosis, through inhibitions of NOX1/2/4/5 expression via epigenetically regulating chromatin accessibility [29] [30] [31] [32] . HDAC inhibitors have displayed clinical efficacy in treating specific tumors 33 . SAHA inhibits both class I and class II HDACs, but selectively alters transcription of as few as 2-5% of genes 34 . Further research is required to determine whether HDAC1 inhibition could be used to reduce cardiovascular risk in OSA patients. H3K79 methylation has been shown to be implicated in several processes of DNA replication and repair of DNA damage 35 . Moreover, H3K79 methylation, shows a high positive correlation with transcriptional activity 36, 37 . In this study, the global H3K79 hypermethylation in OSA patients with high hsCRP, which has been linked with a high cardiovascular risk 15 , suggest that H3K79me3 may serve as an endogenous protective mechanism against chronic IHR-induced DNA damage in OSA. Most KDM enzymes are structurally similar to the HIF hydroxylase factor inhibiting HIF-1, suggesting that KDM enzymes may act as molecular oxygen sensors in the cell 38 . Hypoxia-inducible KDMs have been shown to support the adaptive and adverse gene transcription induced by HIF-1α, and they can also control genome-wide chromatin landscape, especially KDMs which demethylate H3K9 and H3K27 sites 39 . The down-regulation of KDM6B in OSA patients with high hypoxic load and incident cardiovascular events in this study suggest that long-term oxidative stress-related insults may impair the maintenance of chromatin landscape and provoke cellular senescence and endothelial dysfunction associated with chronic IHR circumstances in OSA. Although previous studies showed that hypoxia either inhibits or induces the enzymatic activity of KMD6B depending on HIF-2α, KDM6B protein levels remained unchanged under hypoxic conditions and decreased upon re-oxygenation [40] [41] [42] . Further study is required to determine whether KDM6B supplementation can reverse H3K79 hypermethylation and ameliorate adverse consequences in severe OSA. One limitation is that this study was conducted using PBMCs; thus, the findings associating KDM6B to future cardiovascular events may not extend to other cell types. Given that a recent U.S. healthcare system-based analysis of mortality and markers of severe morbidity identify sleep apnea as a risk factor for COVID-19 mortality, our results may provide particular insight into immune function with OSA and discover mechanistic pathways underlying COVID-19 morbidity 43 . Another limitation is that we did not check some histone modifying enzymes known to regulate histone methylation, such as other JmjC-KDM demethylases and G9a methylase 44, 45 .

In conclusions, H3K23/H3K36 hypoacetylation is associated with the development of prevalent hypertension or disease severity in patients with sleep-disordered breathing, probably through up-regulation of HDAC1, while H3K79 hypermethylation is associated with higher risk of incident cardiovascular diseases, probably through down-regulation of KDM6B. HIF-1α and HIF-2α gene promoter-specific H3K36 hypoacetylation may play a role in regulating adaptive gene responses to chronic IHR injury of OSA. HDAC1 inhibition can reduce oxidative stress induced by IHR through inhibition of NOX1. These findings provide further insights into novel epigenetic mechanisms by which chronic IHR leads to adverse consequences in OSA, and opens the possibility of using HDAC1 inhibitor in preventing the morbidities and mortality. (E) OSA patients with low KDM6B protein expression had a higher risk for recent-onset cardiovascular events or hypertension in the following 3 years than those with high KDM6B protein expression. (F) HDAC3 protein expression was decreased in OSA patients with high hypoxic load. (G) HDAC1 gene expression was increased in OSA patients with severe excessive daytime sleepiness (EDS). (H) H3K36Ac enrichment over the HIF-1α gene promoter region was decreased in OSA patients. This histone marker was negatively correlated with (I) apnea hypopnea index (AHI) and (J) oxygen desaturation index (ODI), and positively with (K) minimum oxygen saturation. *adjust for age, body mass index, gender, smoking history, alcoholism history, and co-morbidities (diabetes mellitus, hypertension, stroke, cardiac disease, chronic kidney disease) by multivariate linear regression analysis. #compared between primary snoring (PS) subjects and obstructive sleep apnea (OSA) patients with a particular phenotype (a high hypoxic load or severe EDS), adjusted by multivariate linear regression analysis. ##compared between OSA patients with a particular phenotype (a high hypoxic load or severe EDS) and those without the phenotype, adjusted by multivariate linear regression analysis. Hollow circle indicates PS subjects; solid star indicates OSA patients. PBMC = peripheral blood mononuclear cell; cum = cumulative; CI = confidence interval. www.nature.com/scientificreports/ www.nature.com/scientificreports/ was obtained from each subject participating in the study aged 20 years or older. All the methods were carried out in accordance with relevant guidelines and regulations. The exclusion criteria included ongoing infections, autoimmune disease, use of immunosuppressive agent in the past 6 months, narcolepsy, severe obesity (body mass index, BMI, ≧35 kg/m 2 ), old age (> 65 year-old), and those with a BMI < 21 kg/m 2 . OSA (apnea hypopnea index, AHI, ≧5 events/hour) and PS (AHI < 5 events/hour) were diagnosed by full night polysomnography examination at the sleep center of Kaohsiung Chang Gung Memorial Hospital 46 . The Epworth Sleepiness Scale (ESS) recorded at the examination was used to measure sleep propensity in every study subject 47 . Prevalent hypertension was defined as systolic blood pressure ≧140 mmHg and/or diastolic blood pressure ≧90 mmHg or medication use at diagnosis of OSA. Incident cardiovascular events (coronary artery disease: angioplasty, coronary artery bypass grafting, myocardial infarction, or angina) or hypertension were defined as those occurred in the following 3 years after the first blood sampling at diagnosis 48 .

Isolation of PBMC RNA and protein from whole blood samples. PBMCs were isolated from heparinized blood of all study subjects using a two-layer Ficoll-Histopaque density gradient centrifugation (His- www.nature.com/scientificreports/ hexamers) were designed and purchased from Roche according to the company's protocols (www. roche-appli ed-scien ce. com), and their sequences are given in 52 . The PCR primers for the two selected gene promoters located from − 300 to + 30 bp of their transcription start site were listed in Table 2 . The conditions for the reaction were: 50 °C, 2 min; 94 °C, 10 min, then 95 °C, 20 s; 60 °C, 30 s for 50 cycles. Resulting PCR products were measured and elaborated by the sequence detector ABI GeneAmp PCR System 9700 (PerkinElmer Biosystems). Histone enrichment was compared by fold enrichment method, in which the ChIP signals are divided by the no-antibody signals, representing the ChIP signal as the fold increase in signal relative to the background signal 53,54 . In vitro human monocyte cell line culture under IHR stimuli. The human monocytic leukemia cell line THP-1 cells obtained from ATCC (1 × 10 6 cells/ml) were re-suspended in a 5 cm culture dish containing 5 ml RPMI 1640 medium, and then exposed to normoxia or IHR in a custom-designed, incubation chambers which are attached to an external O2-CO2-N2 hand-driven controller as previously described 55 . Air-phase set point for IHR consisted of a 25-min hypoxic period (0% O2 and 5% CO2), followed by 35 min of re-oxygenation (21% O2 and 5% CO2), 7 h each day for 9 days 56 . Control cells were maintained in NOX condition for the same durations. HDAC inhibitor, SAHA (Sigma-Aldrich, Saint Luis, MO, USA), and HAT inhibitor, Garcinol (Sigma-Aldrich, Saint Luis, MO, USA), were used to inhibit or augment HDAC expression, respectively. H2DCFDA (catalog no. D6883; Sigma, USA) was used to measure THP-1 intracellular ROS. Cell-associated mean fluorescent intensity was measured by flow cytometry in FL1 channel at excitation and emission wavelengths of 488 and 535 nm, respectively, using the CytomicsTM FC500 (Beckman Coulter ; USA ). Gene expression levels of the NADPH oxidase NOX1/2/4/5 genes were determined using quantitative RT-PCR method.

Continuous values were expressed as mean ± standard deviation (SD). The differences between two groups were analyzed using the Student's t-test, Mann-Whitney U-test, or X 2 -test, as appropriate. Subgroup comparisons of continuous variables in the validation cohort were performed using the one-way ANOVA with LSD method for post-hoc tests, followed by multivariate linear regression analysis to adjust for all potential confounding factors (age, BMI, gender, smoking, alcoholism, and co-morbidities), and to obtain adjusted p values. The null hypothesis was rejected at p < 0.05. All analyses were performed using SPSS software version 20.0 (SPSS Corp., Chicago).

Board of Chang Gung Memorial Hospital, Taiwan (Certificate number: 102-3887B). Written informed consent was obtained from each subject participating in the study.

The data that support the findings of this study are available in supplementary information online and from the corresponding author upon reasonable request.

Phenotypes in obstructive sleep apnea: A definition, examples and evolution of approaches

Consequences of obstructive sleep apnea: Cardiovascular risk of obstructive sleep apnea and whether continuous positive airway pressure reduces that risk

The role inflammatory response genes in obstructive sleep apnea syndrome: A review

Positive airway pressure therapy for obstructive sleep apnea

The impact of obstructive sleep apnea and PAP therapy on all-cause and cardiovascular mortality based on age and gender: Aa literature review

Epigenetic programming of hypoxic-ischemic encephalopathy in response to fetal hypoxia

Whole genome DNA methylation analysis of obstructive sleep apnea: IL1R2, NPR2, AR, SP140 methylation and clinical phenotype

H3K23me2 is a new heterochromatic mark in Caenorhabditis elegans

Histone lysine methyltransferases in biology and disease

H3K56me3 is a novel, conserved heterochromatic mark that largely but not completely overlaps with H3K9me3 in both regulation and localization

Epigenetic regulation by histone demethylases in hypoxia

Histone acetylation and histone deacetylation in neuropathic pain: An unresolved puzzle?

Epigenetic regulation of hypoxia-responsive gene expression: Focusing on chromatin and DNA modifications

Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: A randomized controlled trial

Obstructive sleep apnea syndrome and cardiovascular disease: The influence of C-reactive protein

Identification of histone H3 lysine 36 acetylation as a highly conserved histone modification

A histone H3K36 chromatin switch coordinates DNA double-strand break repair pathway choice

The role of cigarette smoke-induced epigenetic alterations in inflammation

Liver histone H3 methylation and acetylation may associate with type 2 diabetes development

Abnormal modification of histone acetylation involved in depression-like behaviors of rats induced by chronically unpredicted stress

Histone acetyltransferase CBP-related H3K23 acetylation contributes to courtship learning in Drosophila

High-resolution mapping of H4K16 and H3K23 acetylation reveals conserved and unique distribution patterns in Arabidopsis and rice

KAT6B promotes LPS-triggered IL-6 production via enhancing recruitment of H3K23 acetylation to IL-6 promoter region

Role of HDAC1 in senescence, aging, and cancer

Histone deacetylase 1 inhibition protects against hypoxia-induced swelling in H9c2 cardiomyocytes through regulating cell stiffness

Regulation of the HIF-1alpha stability by histone deacetylases

HDAC3 mediates cardioprotection of remifentanil post-conditioning by targeting GSK-3beta In H9c2 cardiomyocytesin hypoxia/reoxygenation injury

Remifentanil postconditioning ameliorates histone H3 acetylation modification in H9c2 cardiomyoblasts after hypoxia/reoxygenation via attenuating endoplasmic reticulum stress

Inhibition of histone deacetylase reduces transcription of NADPH oxidases and ROS production and ameliorates pulmonary arterial hypertension. Free Radic

Epigenetic regulation of vascular NADPH oxidase expression and reactive oxygen species production by histone deacetylase-dependent mechanisms in experimental diabetes

The enzyme activity of histone deacetylase 8 is modulated by a redox-switch

Pharmacological inhibition of histone deacetylase reduces NADPH oxidase expression, oxidative stress and the progression of atherosclerotic lesions in hypercholesterolemic apolipoprotein E-deficient mice; potential implications for human atherosclerosis

Action mechanisms of histone deacetylase inhibitors in the treatment of hematological malignancies

SAHA, a HDAC inhibitor, has profound anti-growth activity against non-small cell lung cancer cells

DOT1L and H3K79 methylation in transcription and genomic stability

Epigenetic control of influenza virus: role of H3K79 methylation in interferon-induced antiviral response

The many faces of histone H3K79 methylation

Advances in hypoxia-inducible factor biology

Hypoxia-inducible histone lysine demethylases: Impact on the aging process and age-related diseases

Hypoxia increases genome-wide bivalent epigenetic marking by specific gain of H3K27me3

The involvement of histone methylation in osteoblastic differentiation of human periosteum-derived cells cultured in vitro under hypoxic conditions

HIF-1-dependent induction of Jumonji domain-containing protein (JMJD) 3 under hypoxic conditions

Sleep apnea and COVID-19 mortality and hospitalization

Epigenetic regulation by histone demethylases in hypoxia

Hypoxia-inducible lysine methyltransferases: G9a and GLP hypoxic regulation, non-histone substrate modification, and pathological relevance

Co-upregulation of Toll-like receptors 2 and 6 on peripheral blood cells in patients with obstructive sleep apnea

The Epworth Sleepiness Scale in service members with sleep disorders

Hypertension is associated with undiagnosed OSA during rapid eye movement sleep

Standardization and quality control studies of "real-time" quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia: A Europe Against Cancer program

Genome-wide gene expression array identifies novel genes related to disease severity and excessive daytime sleepiness in patients with obstructive sleep apnea

Investigating regulatory factors and their DNA binding affinities through real time quantitative PCR (RT-QPCR) and chromatin immunoprecipitation (ChIP) assays

Histone H3K14 hypoacetylation and H3K27 hypermethylation along with HDAC1 up-regulation and KDM6B down-regulation are associated with active pulmonary tuberculosis disease

TRIM37 is a new histone H2A ubiquitin ligase and breast cancer oncoprotein

Chromatin immunoprecipitation: optimization, quantitative analysis and data normalization

Co-upregulation of Toll-like receptors 2 and 6 on peripheral blood cells in patients with obstructive sleep apnea

Obstructive sleep apnea and intermittent hypoxia increase expression of dual specificity phosphatase 1

The authors acknowledge the technical support provided by the Genomic and Proteomic Core Laboratory, and Internal Medicine Core Facility of the Kaohsiung Chang Gung Memorial Hospital. We wish to thank Ms. Shu-Jun Kong, Ms. Lian-Rong Liu, and Mr. Wei-Zhe Liu for manual scoring of all PSG. We also thank Chih-Yun Lin and the Biostatistics Center, Kaohsiung Chang Gung Memorial Hospital for statistics work. This is not an industry-sponsored study. All the authors declare that they have no potential conflicts of interest or financial support in any for-profit business agency.

The authors declare no competing interests.

The online version contains supplementary material available at https:// doi. org/ 10. 1038/ s41598-021-00052-9.Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/.